elative mild phenotype. In conclusion, our findings expand the clinical spectrum of AFG3L2 mutations and suggest a new subtype of late-onset SCAR caused by biallelic AFG3L2 mutations. AFG3L2 mutation should be considered in patients with late onset, slowly progressive cerebellar ataxia, even without an autosomal dominant family history. the examiner.